These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32504710)

  • 1. Biosensing: The best alternative for conventional methods in detection of Alzheimer's disease biomarkers.
    Mobed A; Hasanzadeh M
    Int J Biol Macromol; 2020 Oct; 161():59-71. PubMed ID: 32504710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis.
    Rezabakhsh A; Rahbarghazi R; Fathi F
    Biosens Bioelectron; 2020 Nov; 167():112511. PubMed ID: 32858422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the development paradigm of biosample-based biosensors for early ultrasensitive detection of alzheimer's disease.
    Karki HP; Jang Y; Jung J; Oh J
    J Nanobiotechnology; 2021 Mar; 19(1):72. PubMed ID: 33750392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer's Disease.
    Phan LMT; Hoang TX; Vo TAT; Pham HL; Le HTN; Chinnadayyala SR; Kim JY; Lee SM; Cho WW; Kim YH; Choi SH; Cho S
    Expert Rev Mol Diagn; 2021 Feb; 21(2):175-193. PubMed ID: 33560154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoarchitectured Bioconjugates and Bioreceptors Mediated Surface Plasmon Resonance Biosensor for
    Nangare S; Patil P
    Crit Rev Anal Chem; 2022; 52(5):1139-1169. PubMed ID: 33426916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A shape-code nanoplasmonic biosensor for multiplex detection of Alzheimer's disease biomarkers.
    Kim H; Lee JU; Song S; Kim S; Sim SJ
    Biosens Bioelectron; 2018 Mar; 101():96-102. PubMed ID: 29054022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-based diagnostic and screening platform using a combination of biosensing signals in Alzheimer's disease.
    Kim HJ; Kim H; Park D; Yoon DS; San Lee J; Hwang KS
    Biosens Bioelectron; 2023 Jun; 230():115246. PubMed ID: 37003061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer's Disease Biomarker Using a Chaotropic Agent.
    Kim H; Lee JU; Kim S; Song S; Sim SJ
    ACS Sens; 2019 Mar; 4(3):595-602. PubMed ID: 30747516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease Biomarker Detection Using Field Effect Transistor-Based Biosensor.
    Le PG; Choi SH; Cho S
    Biosensors (Basel); 2023 Nov; 13(11):. PubMed ID: 37998162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosensors for Alzheimer's disease biomarker detection: A review.
    Shui B; Tao D; Florea A; Cheng J; Zhao Q; Gu Y; Li W; Jaffrezic-Renault N; Mei Y; Guo Z
    Biochimie; 2018 Apr; 147():13-24. PubMed ID: 29307704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design principles and fundamental understanding of biosensors for amyloid-β detection.
    Zhang Y; Ren B; Zhang D; Liu Y; Zhang M; Zhao C; Zheng J
    J Mater Chem B; 2020 Jul; 8(29):6179-6196. PubMed ID: 32355946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.
    Cohen AD; Landau SM; Snitz BE; Klunk WE; Blennow K; Zetterberg H
    Mol Cell Neurosci; 2019 Jun; 97():3-17. PubMed ID: 30537535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.
    Spallazzi M; Barocco F; Michelini G; Immovilli P; Taga A; Morelli N; Ruffini L; Caffarra P
    Acta Neurol Belg; 2019 Sep; 119(3):445-452. PubMed ID: 30847669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D; Hampel H
    Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
    Koychev I; Hofer M; Friedman N
    J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Concise Overview of Biosensing Technologies for the Detection of Alzheimer's Disease Biomarkers.
    Talebi M; Esmaeeli H; Talebi M; Farkhondeh T; Samarghandian S
    Curr Pharm Biotechnol; 2022; 23(5):634-644. PubMed ID: 34250871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthreshold Amyloid Predicts Tau Deposition in Aging.
    Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
    J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.
    Wright LM; Stein TD; Jun G; Chung J; McConnell K; Fiorello M; Siegel N; Ness S; Xia W; Turner KL; Subramanian ML
    J Alzheimers Dis; 2019; 68(4):1429-1438. PubMed ID: 30856114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA Dysregulation in Alzheimer's Disease.
    Putteeraj M; Fairuz YM; Teoh SL
    CNS Neurol Disord Drug Targets; 2017; 16(9):1000-1009. PubMed ID: 28782488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.